AI assistant
Sending…
Pluri Inc. — Director's Dealing 2019
Apr 8, 2019
6990_dirs_2019-04-08_d69f357c-43cb-430f-87d0-a97c1a5137ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2019-04-08
Reporting Person: SHORRER DORON (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-04-08 | Common Stock | P | 14286 | $0.70 | Acquired | 464744 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-04-08 | Common Stock Warrant | $0.70 | P | 14286 | Acquired | 2024-04-08 | Common Stock (14286) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 432500 | Indirect |
Footnotes
F1: The common stock and common stock warrant were acquired in the issuer's public underwritten offering of units, in which each unit consisted of one share of common
stock and an accompanying common stock warrant to purchase one share of common stock, at a price of $0.70 per unit. The price paid per unit is reflected in Table I.
F2: The common stock warrants were exercisable immediately upon their issuance.
More from Pluri Inc.
Regulatory Filings
2026
Jun 2
Report Publication Announcement
2026
Jun 2
Report Publication Announcement
2026
Jun 1
Capital/Financing Update
2026
Jun 1
Capital/Financing Update
2026
Jun 1
Report Publication Announcement
2026
May 14
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 23
Report Publication Announcement
2026
Apr 23